Theravance Biopharma

California Life Sciences Association launches, following BayBio, California Healthcare Institute merger

Friday, May 15, 2015

The California Life Sciences Association (CLSA) has officially launched as a representation for California’s life sciences sector. CLSA now is the largest state and regional life sciences advocacy group in the country, with more than 750 members. The organization advances California’s life sciences innovation ecosystem by advocating for effective national, state and local public policies and supporting entrepreneurs and life sciences businesses. CLSA is the result of a completed merger between BayBio and California Healthcare Institute.

[Read More]

Theravance Biopharma, Mylan partner for COPD

Wednesday, February 4, 2015

Theravance Biopharma, based in south San Francisco, Calif., and Mylan, a global generic and specialty pharmaceuticals company headquartered in Cecil Township, Pa., will partner on the development and commercialization of TD-4208, a novel investigational once-daily nebulized long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD) and other respiratory diseases.

[Read More]

Theravance appoints Michael W. Aguiar as president, CEO

Friday, August 8, 2014

Theravance has appointed Michael W. Aguiar as president and CEO effective August 15, and as a member of the board of directors effective immediately. Aguiar plans to continue to as Theravance’s senior vice president and chief financial officer until his replacement is identified and appointed. 

[Read More]